.png){kind=icon}
D
Daniel P. Judge
H-index:94
Citation Count:3.7万
Views:0
Biography
No content for now.
Education
No content for now.
Work Experience
No content for now.
Honors & Awards
No content for now.
Comparative Effectiveness of TTR Stabilizers for the Treatment of ATTR-CM Using Real-World Evidence
真实世界证据下TTR稳定剂治疗ATTR-CM的疗效比较
Correction: Vutrisiran Health Care Resource Utilization, Costs, Discontinuation, and Mortality: A Real-World Claims Analysis
更正：Vutrisiran医疗资源利用、成本、停药和死亡率：一项真实世界索赔分析
Vutrisiran Health Care Resource Utilization, Costs, Discontinuation, and Mortality: A Real-World Claims Analysis
Vutrisiran治疗中的医疗资源利用、成本、停药及死亡率：一项真实世界理赔数据分析
A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy
ATTRibute-CM研究的通俗语言综述：acoramidis治疗转甲状腺素蛋白淀粉样变性心肌病的有效性与安全性
Exploring the Nexus of Genotype and Phenotype in Nexilin-Related Genetic Cardiomyopathy
探索Nexilin相关遗传性心肌病中基因型与表型的关联
Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis from ATTRibute-CM
Acoramidis对ATTR-CM中复发性及累积心血管结局的影响：ATTRibute-CM研究的探索性分析
JACC
IF0
KLK15 alters connective tissues in hypermobile Ehlers-Danlos syndrome
KLK15改变了高-mobile型埃勒斯-当洛斯综合征中的结缔组织
iScience
IF4.1
Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse Cohort
新型基于基因组检测的Lp(a)预测方法在多样化队列中识别ASCVD风险
Hypertension increases PPV for polycystic kidney disease in PKD1 and PKD2 variant carriers
高血压增加了PKD1和PKD2变异携带者患多囊肾病的阳性预测值。
Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up
阿卡兰定用于转甲状腺素蛋白淀粉样变性心肌病：开放标签扩展研究长期随访
Retrospective study shows pharmacogenomic testing could reduce adverse events associated with clopidogrel use by 38%
回顾性研究显示，药物基因组学检测可将氯吡格雷使用相关的不良事件减少38%。
CIRCULATION
IF38.6
Quantifying the influence of baseline body weight on sex differences in semaglutide-associated weight loss
量化基线体重对司美格鲁肽相关体重减轻的性别差异的影响
CIRCULATION
IF38.6
